TipRanks
Go Ultimate55% OFF

Healius Limited (HLS) Share Price & Analysis

HLS Stock Chart & Stats

A$0.50A$0.01(2.06%)
At close: 4:00 PM GMT+11
AU$0.35AU$0.4AU$0.45AU$0.53 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
AUD 0.48 - AUD 0.51
52-Week Range
AUD 0.30 - AUD 1.07
Previous Close
AUD 0.49
Volume
1.06M
Average Volume (3M)
4.70M
Market Cap
AUD 359.46M
Enterprise Value
AUD 1.21B
Total Cash (Recent Filing)
AUD 67.20M
Total Debt (Recent Filing)
AUD 998.70M
Price to Earnings (P/E)
―
Beta
1.14
Next Earnings
Feb 24, 2027 (Est.)
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Persistent Cash Generation

Persistent positive operating and free cash flow show that Healius continues converting diagnostic activity into liquidity despite accounting losses. This supports debt reduction, ongoing operations, and selective investment, providing a durable financial buffer over the next several quarters.

Deleveraging Progress

Meaningful debt reduction improves financial resilience and lowers the burden on future cash flows. Although equity has contracted, continued deleveraging gives Healius greater capacity to manage its obligations and fund the business through changing healthcare demand.

Revenue Recovery

The recovery in revenue indicates renewed demand for Healius's pathology and imaging services after the FY2023 contraction. Sustained top-line improvement would strengthen operating leverage, support network utilisation, and create a better foundation for restoring profitability.

Bears Say

Persistent Net Losses

Four consecutive years of net losses indicate that revenue recovery has not yet translated into durable shareholder earnings. Continued losses can restrict reinvestment, weaken equity, and leave the company more dependent on operating cash flow to support obligations and strategic initiatives.

Weak Margin Quality

Weak and unstable margins suggest Healius has limited earnings conversion from its diagnostic revenue base. Thin operating profitability reduces the cushion against cost pressures or reimbursement changes and makes future earnings improvement dependent on sustained efficiency gains.

Contracted Equity Base

A substantially smaller equity base reduces balance-sheet flexibility and leaves less capacity to absorb further losses. Combined with deeply negative recent returns, this weakens the platform for long-term capital allocation and increases the importance of maintaining positive cash generation.

Healius Limited News

HLS FAQ

What was Healius Limited’s price range in the past 12 months?
Healius Limited lowest share price was AU$0.30 and its highest was AU$1.07 in the past 12 months.
What is Healius Limited’s market cap?
Healius Limited’s market cap is AU$359.46M.
When is Healius Limited’s upcoming earnings report date?
Healius Limited’s next earnings report is estimated for Feb 24, 2027 (not yet confirmed), which is in 114 days.
How were Healius Limited’s earnings last quarter?
Healius Limited released its earnings results on Aug 18, 2026. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of AU$0.001 by -AU$0.004.
Is Healius Limited overvalued?
According to Wall Street analysts Healius Limited’s price is currently Overvalued.
Does Healius Limited pay dividends?
Healius Limited pays a Notavailable dividend of AU$0.413 which represents an annual dividend yield of ―. See more information on Healius Limited dividends here
What is Healius Limited’s EPS estimate?
Healius Limited’s EPS estimate is -0.01.
How many shares outstanding does Healius Limited have?
Healius Limited has 726,178,800 shares outstanding.
What happened to Healius Limited’s price movement after its last earnings report?
Healius Limited reported an EPS of -AU$0.003 in its last earnings report, missing expectations of AU$0.001. Following the earnings report the stock price went down -5.618%.
Which hedge fund is a major shareholder of Healius Limited?
Currently, no hedge funds are holding shares in AU:HLS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology